Lars Bode, PhD: Potential Effects of HMOs on Adult Gut Microbiome Lars Bode, PhD discusses the health benefits of Human Milk Oligosaccharides (HMOs) and how research has shown ways HMOs can effect the adult microbiome. Positive effects are seen specifically in breastfed infants, where it has been identified to raise levels of two prime fucosyllactose (2′FL).

In this Clinical Minute, Nikky Contractor, PhD discusses oligosaccharides. 2’-fucosyllactose, also known as 2'-FL and pronounced “two F L,” is the most abundant human milk oligosaccharide (HMO) in human breast milk. Human milk contains many chemical structures that support the growth of beneficial bacteria in infants. The bacteria that are beneficial to infants are also beneficial in adults and support the growth of beneficial bacteria. 2'FL is also a “decoy receptor” that can bind with pathogenic bacteria and prevent binding…

Prebiotics and Quality Carbohydrates: Enhancing Digestive Health Prebiotics are non-digestible carbohydrates that selectively stimulate the growth and activity of beneficial gut bacteria. Some beneficial gut bacterial can metabolize prebiotics, which gives them a growth advantage. Some prebiotics have more specialized benefits and can play a protective role in gut function. This is especially true for selected oligosaccharides called two prime fucosyllactose, or 2’FL, that are naturally produced and are identical to oligosaccharides originally identified in breast milk, referred to as…

Small intestinal bacterial overgrowth (SIBO) is a disorder characterized by an excessive concentration of bacteria in the small intestine (exceeding 105 organisms/mL). Patients with SIBO commonly report abdominal pain, flatulence, bloating, and diarrhea, and may experience malabsorption and weight loss in more severe cases.1 The standard regimen to manage SIBO has been antibiotic therapy, but this may disrupt the normal balance of the gut microbiota and can increases the risk of developing antibiotic resistance. Further, the antibiotics used are often bacteriostatic, not…

by Ashley Jordan Ferira, PhD, RDN Recent research from three well-known cohorts, The Nurses’ Health Study (NHS), NHS2 and Health Professionals’ Follow-Up Study (HPFS), reveals that higher magnesium intake is associated with lower risk of type 2 diabetes (T2D), particularly in diets with poor carbohydrate quality.1 Green leafy vegetables, unrefined whole grains, and nuts are richest in magnesium, while meats and milk contain a moderate amount.2 Refined foods, like carbohydrates (carb), are poor sources of magnesium. Diets with poor carb quality are characterized by…

Frank Hu, MD, PhD at Nutrition Pro 2015: Translating Genetic Information in Nutrition Practice Dr. Frank Hu of the Harvard T.H. Chan School of Public Health discusses the role of genetic information, prediction of chronic disease, and nutrition interventions for improved health. This presentation comes from Nutrition Pro 2015 and contains valuable information for clinical translation of genetic information for improved nutrition practice. Genes play only a small role in our overall health outcomes. Other genetic determinants, such as…

Hypertension (HTN) affects more than a third (32.6%) of Americans and is a major risk factor for heart disease and mortality.1 Unfortunately, the exact mechanisms as to development and maintenance of this condition are yet to be understood. It has been suggested that HTN is associated with a fundamental defect in the ability for the kidneys to excrete sodium.2 Salt sensitivity of blood pressure (BP) is a measurable, physiological, trait where an increase in dietary sodium intake leads to an increase in…

Daily consumption of the probiotic strain Lactobacillus salivarius UCC118 helped relieve severity of gastrointestinal (GI) symptoms associated with small intestinal bacterial overgrowth (SIBO), according to a pilot quality improvement study. The study participants (n=29) were recruited from patients who presented to the Cleveland Clinic Center for Gut Rehabilitation and Transplantation outpatient clinic (Cleveland, OH). Participants consumed the probiotic strain Lactobacillus salivarius UCC118 in an oral supplement (108 CFU/capsule daily) for 90 days in addition to standard therapy. GI symptoms consistent…

Dyslipidemia is a prominent risk factor for atherosclerotic cardiovascular disease (CVD) and impacts over half of US adults. Lifestyle interventions, particularly those incorporating medical nutrition therapy, are essential in the management of dyslipidemia, to halt progression towards advanced CVD and metabolic disease. The primary objective of this multi-site, prospective case series was to measure changes in the plasma atherogenic lipid profile and metabolic syndrome-related variables in 24 overweight patients with dyslipidemia at baseline, 4 weeks after daily consumption of a…

This open-label, multi-clinic study in 12 patients with digestive disorders demonstrated that consuming 2 servings daily of an innovative structured nutrition therapy for 6 weeks: Reduced GI symptoms and improved overall GI quality of life Increased production of SCFA, including butyrate Increased levels of Bifidobacterium spp. Reduced potential harmful intestinal microbiota Despite the limited sample size in this preliminary study, this targeted nutrition therapy approach offers promise as a novel nutritional therapy for patients with compromised gut function. Download the…